Owens & Minor, Inc. (NYSE:OMI) Shares Sold by Rhumbline Advisers

Rhumbline Advisers reduced its position in Owens & Minor, Inc. (NYSE:OMI) by 4.1% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 223,320 shares of the company’s stock after selling 9,652 shares during the period. Rhumbline Advisers owned about 0.29% of Owens & Minor worth $2,017,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in Owens & Minor by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 8,915,756 shares of the company’s stock valued at $116,529,000 after buying an additional 107,092 shares in the last quarter. Coliseum Capital Management LLC increased its holdings in shares of Owens & Minor by 31.3% in the 4th quarter. Coliseum Capital Management LLC now owns 4,785,964 shares of the company’s stock valued at $62,553,000 after acquiring an additional 1,141,483 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Owens & Minor by 13.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company’s stock worth $30,127,000 after acquiring an additional 276,807 shares during the period. Kennedy Capital Management LLC grew its stake in Owens & Minor by 15.5% during the 4th quarter. Kennedy Capital Management LLC now owns 1,216,859 shares of the company’s stock worth $15,904,000 after buying an additional 163,184 shares during the last quarter. Finally, Northern Trust Corp grew its position in Owens & Minor by 13.7% in the 4th quarter. Northern Trust Corp now owns 968,101 shares of the company’s stock worth $12,653,000 after purchasing an additional 116,754 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Stock Performance

NYSE OMI opened at $7.93 on Tuesday. The stock has a market cap of $612.32 million, a PE ratio of -12.19, a P/E/G ratio of 0.20 and a beta of 1.31. The firm has a 50-day moving average of $7.11 and a 200-day moving average of $9.74. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. Owens & Minor, Inc. has a 52-week low of $6.07 and a 52-week high of $17.30.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings results on Saturday, May 10th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.03. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. During the same period last year, the business posted $0.19 EPS. The business’s quarterly revenue was up .7% on a year-over-year basis. On average, sell-side analysts anticipate that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor declared that its board has authorized a stock buyback program on Friday, February 28th that allows the company to buyback $100.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 13.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its stock is undervalued.

Analyst Upgrades and Downgrades

OMI has been the topic of several research reports. Robert W. Baird upped their price target on Owens & Minor from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Friday, June 6th. Citigroup decreased their target price on Owens & Minor from $13.00 to $11.00 and set a “buy” rating for the company in a research report on Thursday, April 17th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a research note on Monday, March 10th. Two analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $12.33.

Insiders Place Their Bets

In related news, major shareholder Coliseum Capital Management, L acquired 225,000 shares of the company’s stock in a transaction dated Wednesday, April 9th. The shares were purchased at an average price of $7.39 per share, for a total transaction of $1,662,750.00. Following the completion of the acquisition, the insider now owns 11,482,955 shares of the company’s stock, valued at approximately $84,859,037.45. This trade represents a 2.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last 90 days, insiders bought 625,000 shares of company stock worth $4,909,150. 3.69% of the stock is currently owned by insiders.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.